Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: 42 - Caught on Camera

Ray Dalio Warns Bitcoin Is Traceable and Not a True Safe-Haven Asset — Michael Saylor Hits Back

Ray Dalio argues Bitcoin lacks privacy and acts as a risk-on asset, while Michael Saylor defends its transparency and scarcity, highlighting its potential as global collateral.

International Business Times UK

Sell in May and Go Away—Starting With These 3 Stocks

Oxford Club's Marc Lichtenfeld identifies three stocks worth selling in May—DexCom, Colgate-Palmolive, and Oracle—and breaks down the risks behind each call.

MarketBeat

Asian shares trade mixed after Wall Street rally despite Iran war worries

Asian shares are trading mixed as optimism encouraged by a record rally on Wall Street clashed with pessimism over worries about surging oil prices and an inflated AI boom

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

SiBone Q1 Earnings Call Highlights

SiBone (NASDAQ:SIBN) raised its full-year 2026 outlook after reporting double-digit revenue growth in the first quarter, with management pointing to new product launches, expanding physician adoption, international momentum and a proposed Medicare reimbursement change as key drivers for the year ahe

MarketBeat

Quantum Computing Q1 Earnings Call Highlights

Quantum Computing (NASDAQ:QUBT) reported a sharp year-over-year increase in first-quarter revenue as recent acquisitions began contributing to results, while management outlined plans to expand manufacturing capabilities and advance its quantum photonics product roadmap. On the company’s first-quar

MarketBeat

U.S Stock Market on Tuesday: S&P 500, Dow Jones, Nasdaq for record trading? These factors will decide

U.S. Stock market investors would hope that S&P 500, Dow Jones, Nasdaq will continue record run.

The Economic Times

Microvast Q1 Earnings Call Highlights

Microvast (NASDAQ:MVST) reported a sharp year-over-year revenue decline in the first quarter of 2026, while management said the drop reflected temporary timing and market challenges rather than a change in the company’s long-term growth strategy. The battery technology company posted first-quarter

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Life360 Q1 Earnings Call Highlights

Life360 (NASDAQ:LIF) reported record first-quarter revenue and raised its full-year outlook, while management said technical issues temporarily weighed on user registration during the quarter but did not derail subscription momentum. Chief Executive Lauren Antonoff said the company’s revenue growth

MarketBeat

Kaltura Q1 Earnings Call Highlights

Kaltura (NASDAQ:KLTR) reported first-quarter 2026 results that exceeded its guidance for revenue and adjusted EBITDA, while also generating positive operating cash flow in a first quarter for the first time in the company’s history, executives said on the company’s earnings call. Co-founder, Chairm

MarketBeat

iHeartMedia Q1 Earnings Call Highlights

iHeartMedia (NASDAQ:IHRT) reported first-quarter 2026 revenue growth that met management’s expectations, while adjusted earnings came in modestly below guidance as the company cited timing of non-cash marketing expenses and softer March advertising demand. Chairman and CEO Bob Pittman said consolid

MarketBeat

Harmonic Q1 Earnings Call Highlights

Harmonic (NASDAQ:HLIT) reported a stronger-than-expected first quarter for fiscal 2026, driven by sharp growth in its broadband business and broader adoption beyond its largest customers, according to comments from executives on the company’s earnings call. President and CEO Nimrod Ben-Natan said t

MarketBeat

U.S. Stock Market set to undergo big correction? Should S&P 500, Nasdaq investors worry? Experts reveal details

U.S. Stock Market: Investors in ‌an S&P 500 index fund may think they are diversified, but this is mostly an illusion. As RBC Wealth Management analysts note, more than $40 of every $100 invested goes into just 10 companies.

The Economic Times

Coherus Oncology Q1 Earnings Call Highlights

Coherus Oncology (NASDAQ:CHRS) said it expects revenue growth for its nasopharyngeal cancer drug LOQTORZI to build through the rest of 2026, while the company prepares for multiple clinical data readouts across its oncology pipeline later this year. On the company’s first-quarter 2026 earnings call

MarketBeat

American Public Education Q1 Earnings Call Highlights

American Public Education (NASDAQ:APEI) reported higher first-quarter 2026 revenue and profitability, raised its full-year outlook and said its newly reorganized business structure is beginning to show operating leverage. President and Chief Executive Officer Angela Selden said total revenue rose 6

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Blink Charging Q1 Earnings Call Highlights

Blink Charging (NASDAQ:BLNK) executives said the company’s first-quarter 2026 results showed progress in its push toward recurring revenue, lower costs and a larger owned DC fast-charging network, while total revenue remained essentially flat from a year earlier. President and CEO Mike Battaglia sa

The Economic Times

S&P 500, Nasdaq hit record highs and Dow Jones rises despite soaring oil prices and Trump warning Iran's ceasefire is 'on life support' - here's how US stock market performed on May 11

S&P 500, Nasdaq, Dow Jones today: The S&P 500 and Nasdaq Composite, closed at record highs Monday, driven by continued investment in technology and AI stocks. Despite rising oil prices due to US-Iran tensions and President Trump's rejection of Iran's proposal, markets largely shrugged off geopolitical concerns, focusing instead on…

Barchart

Stocks Settle Higher on Strong Earnings

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.19%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.29%. June E-mini S&P futures (ESM26 ) rose +0.18%, and June E-mini Nasdaq futures...

MarketBeat

MBX Biosciences Obesity Day Spotlights Monthly GLP-1 Hope and Pipeline Push

MBX Biosciences (NASDAQ:MBX) used its Obesity Day event to outline preliminary clinical data for its lead obesity candidate MBX 4291, introduce a new preclinical obesity program and reiterate key development milestones across its endocrine and metabolic disease pipeline. President and CEO Kent Hawr

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

FormFactor Targets Revenue Doubling by 2030 on AI Chip Testing Boom

FormFactor (NASDAQ:FORM) laid out a plan to double revenue by 2030 during an investor day presentation at the Nasdaq market site in Times Square, with executives pointing to growth in high-performance computing, advanced packaging, high-bandwidth memory and co-packaged optics as the primary drivers.

MarketBeat

Inter & Co. Sets ‘Rule of 50’ Target as Digital Bank Pushes Growth, ROE Gains

Inter & Co. Inc. (NASDAQ:INTR) outlined a new growth and profitability framework at its Owners' Day event at Nasdaq, building on its prior 60-30-30 plan and introducing a new “Rule of 50” target that combines revenue growth and return on equity. Rafaela Vitória, Inter’s Investor Relations Offic

MarketBeat

Exagen Q1 Earnings Call Highlights

Exagen (NASDAQ:XGN) reported record first-quarter revenue and reaffirmed its full-year outlook, as executives said growth in testing volume, improved reimbursement execution and expanding clinician adoption helped offset a weather-related disruption early in the quarter. The autoimmune diagnostics

Kiplinger

Cerebras IPO: Should You Buy CBRS Stock?

The Cerebras IPO is one of the biggest offerings of the year so far, with the AI company making its market debut on Thursday, May 14.

The Economic Times

Ahead of Market: 10 things that will decide stock market action on Tuesday

Indian benchmark indices experienced a significant sell-off on Monday, marking their third consecutive session of decline. The Nifty50 and BSE Sensex both tumbled, led by banking, automobile, and energy sectors amid investor risk aversion. Analysts suggest a weakening trend with immediate support for the Nifty at 23,700.

MarketBeat

Inhibrx Biosciences’ INBRX-106 Combo Tops KEYTRUDA Alone in Phase 2 Cancer Study

Inhibrx Biosciences (NASDAQ:INBX) reported interim randomized Phase 2 data for INBRX-106 in combination with Merck’s KEYTRUDA in first-line PD-L1-positive head and neck squamous cell carcinoma, with Chief Executive Officer Mark Lappe saying the results showed a higher confirmed response rate and dee

MarketBeat

Telos Q1 Earnings Call Highlights

Telos (NASDAQ:TLS) reported a stronger-than-expected first quarter for fiscal 2026, with revenue and adjusted EBITDA exceeding the company’s guidance as growth in TSA PreCheck enrollment activity and execution across large programs helped lift results. Executive Vice President and Chief Financial O

1 … 41 42 43 44

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.